SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-012960
Filing Date
2017-03-06
Accepted
2017-03-06 16:14:55
Documents
3
Period of Report
2017-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v461178_8k.htm 8-K 24210
2 EXHIBIT 10.1 v461178_ex10-1.htm EX-10.1 108480
3 EXHIBIT 99.1 v461178_ex99-1.htm EX-99.1 12561
  Complete submission text file 0001144204-17-012960.txt   146902
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 17668045
SIC: 2836 Biological Products, (No Diagnostic Substances)